Wang Yanhong, Luo Gongwen, Shen Mou, Ge Xin, Huang Yanyan, Wei Tian, Chen Xianchuan
Shanghai University of Traditional Chinese Medicine Yueyang Hospital Chongming Branch of Integrated Traditional Chinese Medicine and Western Medicine.
Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, China.
Medicine (Baltimore). 2020 Nov 20;99(47):e23225. doi: 10.1097/MD.0000000000023225.
The outbreak of a novel coronavirus (2019-nCoV)-infected pneumonia is currently ongoing all over the world. The treatment scheme is generally isolation treatment and symptomatic support treatment. While the majority of patients recover from this disease through methods above, COVID-19 Infection severely affect the physical and mental health of rehabilitation patients, as well as their living quality. Thus, meditative movement is needed to improve outcome of COVID-19 patients in recovery period.
We will conduct systematic searches to identify all relevant studies without any language limitation from the following electronic databases from inception to October 2020: Medline, Ovid, PubMed, Embase, Cochrane Library, Google Scholar, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), Chinese Biomedical Database, Chinese Biomedical Literature Service System and Wan fang Database. At the same time, we will search the following Clinical trial registries to identify records of on-going or completed but not yet published trials, including WHO International Clinical Trials Registry Platform (ICTRP), Trials Register of Promoting Health Interventions (TRoPHI) and Chinese Clinical Trial Registry (ChiCTR). No limits will be placed on language. The article will study the effect of meditative movement on the quality of life of convalescent patients. The main outcome will be the effect of meditative movement on the quality of life of patients in recovery period. The secondary results will select accompanying symptoms (including myalgia, cough, sputum, runny nose, pharyngalgia, anhelation, chest distress, nausea, vomiting, anorexia, diarrhea), disappearance rate, negative COVID-19 results rate on 2 consecutive occasions (not on the same day), the quality of life improved, CT image improvement, average hospitalization time, occurrence rate of common type to severe form, clinical cure rate, and mortality. Data collection and management 3 authors will independently carry out data from eligible studies in a pretested and standardized Microsoft Excel sheet, with reciprocal validation of data extraction results. Data analysis and quantitative data synthesis will be performed using RevMan software (V.5.3).
The findings of the study will provide new and relatively high-quality evidence in meditative movement treatment for COVID-19.
The conclusion of systematic review will provide evidence to judge whether meditative movement is an effective intervention for patient with COVID-19 in recovery period.
CRD42020210256.
新型冠状病毒（2019 - nCoV）感染的肺炎疫情目前正在全球范围内蔓延。治疗方案一般为隔离治疗和对症支持治疗。虽然大多数患者通过上述方法康复，但新型冠状病毒肺炎严重影响康复患者的身心健康及其生活质量。因此，需要冥想运动来改善新型冠状病毒肺炎患者恢复期的预后。
我们将进行系统检索，以识别从创建到2020年10月期间来自以下电子数据库的所有相关研究，无任何语言限制：Medline、Ovid、PubMed、Embase、Cochrane图书馆、谷歌学术、中国知网（CNKI）、维普中文科技期刊数据库（VIP）、中国生物医学数据库、中国生物医学文献服务系统和万方数据库。同时，我们将检索以下临床试验注册库，以识别正在进行或已完成但尚未发表的试验记录，包括世界卫生组织国际临床试验注册平台（ICTRP）、促进健康干预试验注册库（TRoPHI）和中国临床试验注册中心（ChiCTR）。不设语言限制。本文将研究冥想运动对康复期患者生活质量的影响。主要结局将是冥想运动对恢复期患者生活质量的影响。次要结果将选择伴随症状（包括肌痛、咳嗽、咳痰、流涕、咽痛、气喘、胸闷、恶心、呕吐、厌食、腹泻）、消失率、连续2次（非同日）新型冠状病毒检测阴性率、生活质量改善情况、CT图像改善情况、平均住院时间、普通型转重型发生率、临床治愈率和死亡率。数据收集与管理 3名作者将独立地在预先测试并标准化的Microsoft Excel工作表中对符合条件的研究数据进行提取，对数据提取结果进行相互验证。数据分析和定量数据合成将使用RevMan软件（V.5.3）进行。
该研究结果将为新型冠状病毒肺炎的冥想运动治疗提供新的且质量相对较高的证据。
系统评价的结论将为判断冥想运动是否为新型冠状病毒肺炎恢复期患者的有效干预措施提供证据。
PROSPERO注册号：CRD42020210256。
